Berlin-based Aiomics has raised €2 million in pre-seed funding at a €10 million valuation to tackle the documentation burden facing Europe’s healthcare sector. The round was led by Vorwerk Ventures with €1 million, joined by Calm/Storm, Norrsken Evolve, Rule30, and several angel investors including Konstantin Othmer, Nicolas Weber, Andrea Kranzer, and Markus Wild.
The company is addressing a critical workforce challenge: Europe is projected to face a shortfall of 4.1 million health workers by 2030, with over 1.2 million already missing as of 2022. In the UK, clinicians spend an average of 13.5 hours per week on documentation, roughly a third of their working time. This administrative load reduces efficiency and drives burnout, with nearly one in three physicians considering leaving their roles.
Aiomics’ AI-powered documentation platform integrates speech, handwriting, and existing records into a single validated workflow. It performs completeness and consistency checks through a human-in-the-loop system, producing structured, coded, and audit-secure data that feeds back into hospital IT systems. The result is fewer errors, faster reimbursements, and more time for patient care.
“I used to choose between time for patients or for compliance” said a head therapist at a partner hospital. “With Aiomics, I regain time and improve compliance.”
The startup was co-founded by Dr. Sven Jungmann, Dr. Nikita Tarasov, and Kirill Schitomirski, a lawyer with prior experience scaling the hospitality-tech platform Numa Group. While its team of four is currently all male, Aiomics is in late-stage discussions with a female product leader for its first hire, signaling a commitment to inclusive hiring practices.
“Aiomics goes beyond transcription by reviewing and quality-assuring patient records before generating outputs” the company noted. Its platform uses multimodal capture and FHIR-based handoff to ensure validated, coded, and reconcilable outputs that align with EU regulations. The company is working toward ISO 13485/27001 certification and MDR compliance.
With the new funding, Aiomics plans to expand across hospitals, rehab centers, and telemedicine providers, aiming to prove measurable reductions in documentation time and faster reimbursement cycles. It also plans to localize its platform for new European markets, starting with Sweden.
“The clinical software landscape is undergoing a fundamental transformation” said Sascha Günther, partner at Vorwerk Ventures. “Unlike traditional software, AI can adapt more granularly to the realities of hospitals and specialties, enabling solutions like Aiomics to integrate faster and more seamlessly.”
